Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Enovis CORP

Get SEC filing alerts via email and in your feed for Enovis CORP

ENOV

Enovis CORP

About Enovis CORP

Enovis Corporation is a medical technology company specializing in developing and distributing high-quality medical devices for reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention to recovery, serving healthcare professionals and consumers worldwide. The company emphasizes innovation, quality, and continuous improvement through its EGX management system, competing with leading global brands in fragmented, highly regulated markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Enovis CORP

1
1
Enovis CORP Enovis Corporation Reports 5.4% Net Sales Increase to $589.2 Million in Q1 2026

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
Enovis CORP Enovis Corporation Reports $1.18 Billion Net Loss and $2.25 Billion Revenue for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Enovis CORP Enovis Corporation Reports $570.9 Million Net Loss in Q3 2025, Despite 8.7% Increase in Sales

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Enovis CORP Enovis Corporation Reports 7.5% Sales Increase and $36.5 Million Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Enovis CORP Enovis Corporation Reports 8.2% Net Sales Increase to $558.8 Million in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Enovis CORP Enovis Corporation Reports 23.5% Revenue Growth to $2.1 Billion Despite Increased Net Loss

Via official filing (AI summary) | over 1 year ago | 0 comments

7
1
Enovis CORP Enovis Corporation Reports 21% Revenue Growth, Operating and Net Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments